[29] Selhub J, Jacques PF, Wilson PWF et al. Vitamin status and intake as primary

determinants of homocysteinaemia in an elderly population. JAMA 1993; 270:2693-8.

[30] Rimm EB, Willett WC, Hu FB et al. Folate and vitamin B6 from diet and supplements

in relation to risk of coronary heart disease among women. Ibid 1998; 279:359-64.

[31] Brouwer IA, van Dusseldorp M, Thomas CMG et al. Low-dose folic acid

supplementation decreases plasma homocysteine concentrations: a randomized trial.

Am J Clin Nutr 1999; 69:99-104.

[32] Malinow MR, Duell PB, Hess DL et al. Reduction of plasma homocysteine levels by

breakfast cereal fortified with folic acid in patients with coronary heart disease. New

Engl J Med 1998; 338:1009-15.

[33] Bronstrup A, Hages M, Prinz-Langenohl R et al. Effects of folic acid and combinations

of folic acid and vitamin B12 on plasma homocysteine concentrations in healthy young

women. Am J Clin Nutr 1998; 68:1104-10.

[34] Boushey CJ, Beresford SAA, Omenn GS et al. A quantitative assessment of plasma

homocysteine as a risk factor for vascular disease: probable benefits of increasing folic

acid intake. JAMA 1995; 274:1049-57.

[35] Homocysteine Lowering Trialists' Collaboration. Lowering blood homocysteine with

folic acid based supplements: meta-analysis of randomised trials. BMJ 1998; 316:894-

8.

[36] Women's Health Initiative (WHI) Dietary Trial and Norwegian Vitamin Trial

(NORVIT). Prev Cardiol. 2006 Summer; 9(3):178-82.

[37] Bonaa KH, Njolstad I, Ueland PM et al. Homocysteine Lowering and Cardiovascular

Events after Acute Myocardial Infarction. N Engl J Med 2006 Apr 13; 354(15):1578-

88. Epub Mar 12

[38] Bottiglieri ET, Crellin RF, Reynolds EH. Folates and neuropsychiatry. In: Bailey L,

editor. Folate in health and disease. New York: Marcel Dekker, 1995; 435-62

Folic Acid and Health: An Overview 53

[39] Joosten E, Lesaffre E, Riezler R et al. Is metabolic evidence for vitamin B12 and folate

deficiency more frequent in elderly patients with Alzheimer's disease? J Gerontol

(series A) Biol Sci Med Sci 1997; 52:M76-9

[40] Clarke R, Smith AD, Jobst KA et al. Folate, vitamin B12 and serum homocysteine

levels in confirmed Alzheimer's disease. Arch Neurol 1998;11:1449-55

[41] Seshadri S, Beiser A, Selhub J et al. Plasma homocysteine as a risk factor for Dementia

and Alzheimer's disease’s. N. Engl. J. Med. 2002; 346: 476-483.

[42] Clarke R, Smith AD, Jobst, KA et al. Folate, Vitamin B12, and serum total

homocysteine levels in confirmed Alzheimer disease. Arch. Neurol. 1998; 55: 1449-

1455.

[43] Snowdon DA, Greiner LH, Mortimer JA et al. Serum folate and the severity of atrophy

of the neocortex in Alzheimer disease: findings from the NUN Study. Am. J. Clin. Nutr.

2000; 71: 993-998.

[44] Quinlivan EP, McPartlin J, Mcnulty H et al. Importance of both folic acid and vitamin

B12 in reduction of risk of vascular disease. Lancet 2002; 359: 227-228.

[45] Refsum H, Nurk E, Smith AD et al. The Hordaland Homocysteine Study (HHS): A

Community-Based Study of Homocysteine, Its Determinants and Associations with

Disease. J. Nutrition 2006, 136:1731S-1740S.

[46] Parnetti L, Bottiglieri T Lowenthal D. Role of Homocysteine in age-related vascualr

and non-vascular diseases. Aging. 1997, 9: 241-257.

[47] Bottiglieri T, Laundy M, Crellin R et al. Homocysteine, folate, methylation and

monoamine metbolism in depression. J Neurol Neurosurg Psychiatry 2000, 69; 228-

232

[48] Guttormsen AB, Ueland PM, Nesthus I et al. Determinants and vitamin responsiveness

of intermediate hyperhomocysteinemia. The HHS. J Clin Invest 1996, 98 (9) 2174-

2183

[49] Taylor MJ, Carney SM, Goodwin GM et al. Folate for depressive disorders: systematic

review and meta-analysis of randomized controlled trials. Journal of

Psychopharmacology 2004, 18 (2): 251-6.

[50] Eichholzer M, Luthy J, Moser U et al. Folate and risk of colorectal, breast and cervix

cancer: the epidemiological evidence. Swiss Med Wkly 2001; 131: 539-549.

[51] Jennings E. Folic acid as a cancer preventing agent. Medical Hypotheses 1995, 45 (3):

297-303.

[52] Cornel MC, Smit DJ and de Jong-van den Berg LT. Folic acid—the scientific debate as

a base for public health policy, Reprod Toxicol 2005, 20 pp. 411–415.

[53] Kim YI. Will mandatory folic acid fortification prevent or promote cancer?, Am J Clin

Nutr 2004, 80: pp. 1123–1128

[54] Kim YI. Role of folate in colon cancer development and progression, J Nutr 2003 133

(suppl 1), pp. 3731S–3739S.

[55] Charles D, Ness AR, Campbell D et al. Taking folate in pregnancy and risk of maternal

breast cancer, BMJ 2004, 329:pp. 1375–1376.

[56] Kotsopoulos J, Medline A and Renlund R et al., Effects of dietary folate on the

development and progression of mammary tumors in rats, Carcinogenesis 2005, 9:pp.

1603–1612

54 Rossana Salerno-Kennedy

[57] Giovannucci E, Rimm EB, Ascherio A et al. Alcohol, low methionine, low folate diets

and risk of colon cancer in men. J Natl Cancer Inst 1995;87:265-73

[58] Glynn SA, Albanes D, Pietinen P et al. Colorectal cancer and folate status: a nested

case-control study among male smokers. Cancer Epidemiol Biomarkers Prev 1996; 5:

487-94.

[59] Benito E, Stigglebout A, Bosch FX, Obrador A, Kaldor J, Mulet M et al. Nutritional

factors in colorectal cancer risk: a case-control study in Majorca. Int J Cancer

1991;49:161-7

[60] Meyer F, White E. Alcohol and nutrients in relation to colon cancer in middle-aged

adults. Am J Epidemiol 1993; 138: 225-36.

[61] Ferraroni M, La Vecchia C, D'Avanzo B, Negri E, Franceschi S, Decarli A. Selected

micronutrient intake and the role of colon cancer. Br J Cancer 1994; 70:1150-5.

[62] Freudenheim JL, Graham S, Marshall JR, Haughney BP, Cholewinski S, Wilkinson G.

Folate intake and carcinogenesis of the colon and rectum. Int J Epidemiol 1991;

20:368-74

[63] Giovannucci E, Stampfer MJ, Colditz GA et al. Multivitamin use, folate, and colon

cancer in women in the Nurses' Health Study. Annals of Internal Medicine 1998, 129

(7): 517-524

[64] Giovannucci E, Stampfer MJ, Colditz GA et al. Folate, methionine, and alcohol intake

and risk of colorectal adenoma. J Natl Cancer Inst. 1993 Jun 2; 85(11):875-84.

[65] KimY, Baik H, Fawaz K et al. Effects of folate supplementation on two provisional

molecular markers of colon cancer: a prospective, randomized trial. Am J Gastroenterol

2001; 96:184-95

[66] Ulvik A, Evenson E, Lien E et al. Smoking, folate and MTHRF reductase status as

interactive determinants of adenomatous and hyperplastic polyps of colorectum. Am J

Med Genet 2001:101:246-54

[67] Kim YI. Does a high folate intake increase the risk of breast cancer? Nutr Rev 2006

Oct; 64: 468-75

[68] Sellers TA, Kushi LH, Cerhan JR et al. Dietary folate intake, alcohol and risk of breast

cancer in a prospective study of postmenopausal women. Epidemiology 2001; 12

(4):420-8

[69] Sellers TA, Grabrick DM, Vierkant RA et al. Does folate intake decrease risk of

postmenopausal breast cancer among women with a family history? Cancer Causes

Control 2004 Mar; 15 (2): 113-20.

[70] Stolzenberg-Solomon RZ, Shih-Chen Chang, Leitzmann MF et al. Folate intake,

alcohol use, and postmenopausal breast cancer risk in the Prostate, Lung, Colorectal

and Ovarian Cancer Screening Trial (PLCO). Am J Clin nutr 2006; 83:895-904.

[71] Larsson SC, Hakansson N, Giovannucci E et al. Folate intake and pancreatic cancer

incidence: a prospective study of Swedish women and men. J Natl Cancer Inst 2006

Mar 15; 98(6):407-13

[72] Larsson SC, Giovannucci E, Wolk A. Dietary folate intake and incidence of ovarian

cancer: the Swedish mammography Cohort. J Natl Cancer Inst 2004 Mar 3; 96(5):396-

402.

Folic Acid and Health: An Overview 55

[73] Campbell NR, How safe are folic acid supplements? Arch Intern Med 1996, 156: pp.

1638–1644.

[74] Eichholzer M, Tonz O, Zimmermann R. Folic acid: a public health challenge. Lancet

2006; 367: 1352-61

[75] Eichholzer M, Luthy J, Moser U et al. Safety aspects of folic acid for the general

population, Schweiz Rundsch Med Prax 2002, 91:pp. 7–16 [in German].

[76] Scott JM. Folate and vitamin B12. Proc Nutr Soc. 1999 May;58(2):441-8

[77] Food and Nutrition Board, Institute of Medicine (1998). Dietary reference intakes for

thiamin, riboflavin, niacin, vitamin B6, folate, vitamin B12, pantothenic acid, biotin, and

choline / a report of the Standing Committee on the Scientific Evaluation of Dietary

Reference Intakes and its Panel on Folate, Other B Vitamins, and Choline and

Subcommittee on Upper Reference Levels of Nutrients. Washington, D.C.: National

Academy Press

[78] Kelly P, McPartlin J, Goggins M et al. Unmetabolised folic acid in serum: acute studies

in subjects consuming fortified foods and supplements. Am J Clin Nutr 1997; 65:1790-

5.

[79] JG Ray, LJ Langman, MM Mamdani and DE Cole, Absence of effect of folic acid flour

fortification on anticonvulsant drug levels, Am J Med (2005), 118 pp. 444–445

[80] Czeizel AE, Metneki J, Dudas I. The higher rate of multiple births after

periconceptional multivitamin supplementation: an analysis of causes, Acta Genet Med

Gemellol (Roma) 1994, 43 pp. 175–184.

[81] Ericson A, Källen B and Åberg A. Use of multivitamins and folic acid in early

pregnancy and multiple births in Sweden, Twin Res 2001, 4 pp. 63–66.

[82] Werler MM, Cragan JD, Wasserman CR et al. Multivitamin supplementation and

multiple births, Am J Med Genet 1997, 71 pp. 93–96.

[83] Martin JA and Park MM. Trends in twin and triplet births: 1980–97, Natl Vital Stat

Reps 1999, 47:pp. 1–16.

[84] Berry RJ, Kihlberg R and Devine O. Impact of misclassification of in vitro fertilisation

in studies of folic acid and twinning: modelling using population based Swedish vital

records, BMJ 2005, 330:pp. 815–818

[85] Vollset, HK Gjessing and A Tandberg et al. Folate supplementation and twin

pregnancies, Epidemiology 2005, 16: pp. 201–205

[86] Katz J, West KP Jr and Khatry SK et al., Twinning rates and survival of twins in rural

Nepal, Int J Epidemiol 2001, 30:pp. 802–807.

[87] Signore C, Mills JL, Cox C et al. Effects of folic acid fortification on twin gestation

rates, Obstet Gynecol 2005, 105:pp. 757–762.

[88] Waller DK, Tita AT and Annegers JF. Rates of twinning before and after fortification

of foods in the US with folic acid, Texas, 1996 to 1998, Paediatr Perinat Epidemiol

2003, 17pp. 378–383.

[89] Shaw GM, Carmichael SL, Nelson V et al. Food fortification with folic acid and

twinning among California infants, Am J Med Genet 2003, 119A pp. 137–140.

[90] Berry RJ, Li Z and Erickson JD et al., Prevention of neural-tube defects with folic acid

in China, N Engl J Med 1999, 341: pp. 1485–1490

[91] Kallen B. Reply to letter to the Editor, Early Hum Dev 2005, 81:pp. 469–470.

56 Rossana Salerno-Kennedy

[92] Munoz-Moran E, Dieguez-Lucena JL, Fernandez-Arcas N et al. Genetic selection and

folate intake during pregnancy, Lancet 1998, 352:pp. 1120–1121.

[93] Lucock M and Yates Z. Folic acid—vitamin and panacea or genetic time bomb? Nat

Rev Genet 2005, 6:pp. 235–240.

[94] Benchalal M, Yahchouchy-Chouillard E, Fouere S et al. Anaphylactic shock secondary

to intravenous administration of folinic acid: a first report, Ann Oncol 2002, 13: pp.

480–481

[95] Rubio IT, Cao Y, Hutchins LF, Westbrook KC, Klimberg VS. Effect of glutamine on

methotrexate efficacy and toxicity. Annals of Surgery 1998, 227 (5): 772-8.

[96] Wolff JE, Hauch H, Kuhl J, Egeler RM, Jurgens H. Dexamethasone increases

hepatotoxicity of MTX in children with brain tumors. Anticancer Research 1998, 18

(4B): 2895-9. .

[97] Kepka L, De Lassence A, Ribrag V et al. Successful rescue in a patient with high dose

methotrexate-induced nephrotoxicity and acute renal failure. Leukemia & Lymphoma

1998, 29 (1-2): 205-9. .

[98] Branda RF, Nigels E, Lafayette AR et al. Nutritional folate status influences the

efficacy and toxicity of chemotherapy in rats. Blood 1998, 92 (7): 2471-6.

[99] Shiroky JB. The use of folates concomitantly with low-dose pulse methotrexate.

Rheumatic Diseases Clinics of North America 1997, 23 (4): 969-80.

[100] Keshava C, Keshava N, Whong WZ et al. Inhibition of methotrexate-induced

chromosomal damage by folinic acid in V79 cells. Mutation Research 1998, 397 (2):

221-8.

[101] Morgan SL, Baggott JE. Folate antagonists in nonneoplastic disease: proposed

mechanisms of efficacy and toxicity". In Bailey LB, Folate in Health and Disease,

1995, 405-433. New York: Marcel Dekker. .

[102] Morgan SL, Baggott JE, Alarcon GS. Methotrexate in rheumatoid arthritis: folate

supplementation should always be given". BioDrugs 1997, 8 (1): 164-175

[103] Morgan SL, Baggott JE, Lee JY, Alarcon GS. Folic acid supplementation prevents

deficient blood folate levels and hyperhomocysteinemia during longterm, low dose

methotrexate therapy for rheumatoid arthritis: Implications for cardiovascular disease

prevention". Journal of Rheumatology 1998, 25 (3): 441-6.https://mawadealmaousoaa.blogspot.com/2023/02/vitamin-b-new-research.html